Skip to content

Access

Open enrollment

The annual window when you can enroll in or change your health plan, and the time to compare GLP-1 coverage across the plans available to you.

By the glp1.how editorial teamReviewed

Open enrollment is the yearly period when you can sign up for, switch, or drop a health plan without needing a qualifying life event. Employers run their own windows, usually in the fall for a January 1 start; the federal and state marketplaces and Medicare each have their own dates. Outside the window, changes are generally limited to special enrollment periods triggered by events like a job change, marriage, or a move.

For anyone on or considering a GLP-1, this is the one moment each year when plan choice is in your hands. It's worth pulling each plan's formulary and checking whether the specific drug is listed, at what tier, and with what prior authorization or step-therapy requirements — coverage can differ sharply between plans from the same employer. It's also the deadline employers work toward when deciding whether to add GLP-1 coverage, so requests to HR land best several months earlier. See how to determine if your formulary covers GLP-1 medications and how employer self-funded plans decide GLP-1 coverage.

For HealthCare.gov Marketplace plans, the window runs November 1 to January 15 (HealthCare.gov (external link)).

insuranceemployercoverage

Revision history

Updated 1 time since Sep 2, 2026 · show changes
  1. v2

    Body revised

  2. v1

    Change tracking began

Related guides

  • How to determine if your insurance formulary covers GLP-1 medications · Before you can get a GLP-1 medication covered, you need to know whether it's on your plan's formulary, and at what tier. This guide shows how to check, what the tiers mean, and who decides what's on the list.
  • Understanding insurance coverage for GLP-1 medications · Coverage for GLP-1 medications depends on three plan rules (formulary, prior authorization, and step therapy) plus a fourth that people often miss: whether the prescription is for diabetes or weight management. This guide explains how each works and how to build your case for coverage.
  • Manufacturer savings cards for every branded GLP-1, including the new pills: a side-by-side guide · Novo Nordisk and Eli Lilly run copay savings cards for their branded GLP-1s, pills and injections alike, but prices, caps, and rules differ by drug, and two cards are closed to new enrollees. This guide lists every current card for Wegovy, Ozempic (pen and the new Ozempic tablets, which replaced Rybelsus in the US in May 2026), Zepbound, Mounjaro, Trulicity, and Foundayo side by side as of September 2026, plus what happened to Saxenda and Victoza.
  • My insurance denied coverage. What now? · First steps after a coverage denial: read the reason, then appeal.
  • Applying for a GLP-1 patient assistance program: step by step · Novo Nordisk's PAP and Lilly Cares can provide Ozempic or Trulicity free to people who qualify by income and insurance status, but as of September 2026 neither covers Wegovy, Zepbound, Saxenda, or Foundayo. Here's who qualifies, the 2026 income limits in dollars, the documents you need, your prescriber's role, turnaround and renewal, what to do if you're denied, and how PAPs differ from savings cards and direct-pay.
  • How compounded GLP-1 medications are made — and how that differs from the branded pens · A compounded GLP-1 is mixed from raw active ingredient at a pharmacy; it does not come off a branded production line. This guide explains how the drug substance is sourced, how the formula and dose are set, how a sterile compounding pharmacy makes the vial, and how that compares with the tightly controlled, FDA-approved process behind Ozempic, Wegovy, and Zepbound.

Related terms

  • Prior authorization · Approval your insurer requires before it will cover a medication.
  • Formulary · The list of medications your plan covers, organized into cost tiers.
  • GLP-1 · A gut hormone (glucagon-like peptide-1) that stimulates insulin release, slows digestion, and reduces appetite; the target of drugs like semaglutide and liraglutide.

Was this helpful?

Improve this page